Synthesis of 4,5-functionalized-2-methyl-6- (substituted aryl) -3 (2H) -pyridazinones: a new group of potent platelet aggregation inhibitors
Dal Piaz, V.; Ciciani, G.; Giovannoni, M.P.
Farmaco 52(3): 173-178
1997
ISSN/ISBN: 0014-827X PMID: 9212451 Document Number: 481929
A series of 4,5-functionalized-2-methyl-6-(substituted phenyl)-3 (2H)-pyridazinones were synthesized and evaluated as platelet aggregation inhibitors in human platelet rich plasma (PRP). The new products generally displayed significant higher activity with respect to the corresponding unsubstituted aryl compounds. Compounds 27 and 31 appeared of particular interest, being their IC50s in the submicromolar range. Structure-activity relationships (SARs) are discussed.
Document emailed within 1 workday
Related Documents
Silveira, I.A.; Paulo, L.G.; Miranda, A.L.; Rocha, S.O.; Freitas, A.C.; Barreiro, E.J. 1991: Substituted pyrazolylhydrazones: a new class of platelet aggregation inhibitors Brazilian Journal of Medical and Biological Research 24(9): 947-951Pinna, G.A.; Curzu, M.M.; Barlocco, D.; Cignarella, G.; Cavalletti, E.; Germini, M.; Berger, K. 1988: Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones Il Farmaco; Edizione Scientifica 43(6): 539-549
Bahekar, S.S.; Shinde, D.B. 2003: Synthesis and anti-inflammatory activity of some [2-amino-6-(4-substituted aryl)-4-(4-substituted phenyl)-1,6-dihydropyrimidine-5-yl]-acetic acid derivatives Acta Pharmaceutica 53(3): 223-229
Arcari, M.; Aveta, R.; Brandt, A.; Cecchetelli, L.; Corsi, G.B.; Solinas, F. 1992: Synthesis and pharmacological evaluation of 2,3-dialkylindoles, "in vitro" inhibitors of thrombin-induced platelet aggregation Farmaco 47(4): 405-425
Ali, K.A.; Ragab, E.A.; Farghaly, T.A.; Abdalla, M.M. 2011: Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents Acta Poloniae Pharmaceutica 68(2): 237-247
Moron, J.; Rautureau, M.; Huel, C.; Pierré, A.; Berthier, L.K.; Atassi, G.; Bisagni, E. 1993: Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives Anti-Cancer Drug Design 8(6): 399-416
Meng, X.Y.; Zhang, X.P.; Chen, X.H.; Yu, A.Z. 1991: Synthesis and antibacterial as well as antineoplastic activities of 2,4-diamino-5-methyl-6-(N-methyl-substituted benzyl) aminoquinazolines Yao Xue Xue Bao 26(5): 383-386
Tarzia, G.; Occelli, E.; Corsico, N.; Luzzani, F.; Barone, D. 1988: Benzodiazepine receptor ligands. Synthesis and preliminary pharmacological evaluation of some 3-aryl-6-thioalkyl-, 3-aryl-6-alkylsulphinyl-, 3-aryl-6-alkylsulphonyl-, and 3-aryl-6-alkoxy-1,2,4-triazolo[3,4-a]phthalazines Il Farmaco; Edizione Scientifica 43(2): 189-201
Farghaly, A.M.; Mohsen, A.; Omar, M.E.; Khalil, M.A.; Gaber, M.A. 1990: Synthesis of 3-aryl-2-substituted-4(3H)-quinazolines as potential antimicrobial agents Farmaco 45(4): 431-438
Turło, J.; Zawadowski, T.; Rump, S.; Jakowicz, I.; Gidyńska, T.; Gałecka, E. 1994: Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide Polish Journal of Pharmacology 46(5): 451-455
Nyby, M.D.; Sasaki, M.; Ideguchi, Y.; Wynne, H.E.; Hori, M.T.; Berger, M.E.; Golub, M.S.; Brickman, A.S.; Tuck, M.L. 1996: Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation Journal of Pharmacology and Experimental Therapeutics 278(2): 503-509
Hagen, V.; Rumler, A.; Klauschenz, E.; Hagen, A.; Heer, S.; Faust, G.; Mitzner, R. 1990: Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines Die Pharmazie 45(4): 240-241
Filacchioni, G.; Nacci, V.; Stefancich, G.; Artico, M. 1974: Synthesis of pyrrolnitrin analogs. IV. 1-aryl-2-methyl-4-p-nitrophenylpyrrole-3-carboxylic acids Il Farmaco; Edizione Scientifica 29(11): 872-882
Zhong, B.H.; Deng, R.X.; Zhong, J.X.; Wang, J. 1990: Synthesis of 2-methyl-5-substituted phenoxy-primaquine and antimalarials activity Yao Xue Xue Bao 25(3): 167-172
Kossakowski, J.; Zawadowski, T.; Kuśmierczyk, J. 1998: Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity Acta Poloniae Pharmaceutica 55(4): 315-318
Gastpar, H. 1982: Platelet aggregation inhibitors and cancer metastasis Annales Chirurgiae et Gynaecologiae 71(3): 142-150
Panchenko, V.M.; Vladimirova, A.V.; Pastorova, V.E.; Sukhanova, S.A. 1980: Fibrinolysis and its inhibitors, and platelet aggregation in rheumatism Laboratornoe Delo 11: 671-675
Zannino, L.; Salvadori, G. 1979: Platelet aggregation inhibitors. their possible use in pediatric pathology Minerva Pediatrica 31(2): 153-169
Wesolowska, O.; Molnar, J.; Westman, G.; Samuelsson, K.; Kawase, M.; Ocsovszki, I.; Motohashi, N.; Michalak, K. 2006: Benzo[a]phenoxazines: a new group of potent P-glycoprotein inhibitors In Vivo 20(1): 109-113
Meng, X.Y.; Zhang, X.P.; Li, B.S.; Li, G.D. 1989: Synthesis and antimalarial and antineoplastic activities of some derivatives of 2,4-diamino-5-methyl-6-substituted benzylaminoquinazolines Yao Xue Xue Bao 24(8): 578-586